Oxford Biomedica plc announced a change to the Group's Board of Directors. Dr. Siyamak ("Sam") Rasty has informed the Board that he will not be standing for re-election at the Company's AGM in June 2023. Sam joined the Board in December 2020 and is a member of the Scientific and Technology Advisory Committee and was a member of the Audit Committee until December 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
220 GBX | +0.69% | +7.32% | 0.00% |
Apr. 18 | Stifel Upgrades Oxford BioMedica to Buy from Hold, Lifts PT | MT |
Apr. 18 | HSBC likes Haleon, cuts Flutter to 'hold' | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 272M | |
-1.67% | 104B | |
+2.34% | 97.42B | |
+0.79% | 22.2B | |
-17.74% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-16.22% | 15.06B | |
+4.10% | 13.98B | |
+33.70% | 11.66B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc Announces Siyamak Rasty Will Not Be Standing for Re-Election